Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 302,835 | 223,881 | 274,219 | 271,646 | 289,507 |
| Cost of Goods | 91,337 | 110,288 | 98,585 | 125,517 | 130,150 |
| Gross Profit | 211,498 | 113,593 | 175,634 | 146,129 | 159,357 |
| Operating Expenses | 201,276 | 231,179 | 198,880 | 172,397 | 345,174 |
| Operating Income | 10,559 | -117,298 | -22,661 | -25,751 | -185,667 |
| Interest Expense | 31,030 | 30,454 | 31,226 | 31,706 | 31,608 |
| Other Income | 341 | 41 | 1,292 | 667 | 5,972 |
| Pre-tax Income | -20,130 | -147,711 | -52,595 | -56,790 | -211,303 |
| Income Tax | 4,621 | 945 | -66,547 | 7,181 | -1,767 |
| Net Income Continuous | -24,751 | -148,656 | 13,952 | -63,971 | -209,536 |
| Net Income | $-24,751 | $-148,656 | $13,952 | $-63,971 | $-209,536 |
| EPS Basic Total Ops | -0.15 | -0.90 | 0.09 | -0.39 | -1.29 |
| EPS Basic Continuous Ops | -0.15 | -0.90 | 0.09 | -0.39 | -1.29 |
| EPS Diluted Total Ops | -0.15 | -0.90 | 0.09 | -0.39 | -1.29 |
| EPS Diluted Continuous Ops | -0.15 | -0.90 | 0.09 | -0.39 | -1.29 |
| EBITDA(a) | $78,280 | $-49,367 | $26,027 | $49,624 | $-108,930 |